APYX

Conviction 72HealthcareScan · Thu, Jun 25, 2026

APYX$4.19+1.58%

ResistanceSupportVol 14

Vol MA14 177.4K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Apyx Medical CorpSURGICAL & MEDICAL INSTRUMENTS & APPARATUSapyxmedical.com ↗

Price4.19

Change+1.58%

Gap-1.46%

Rel volume1.98×

Avg volume175.56K

Avg $ vol762.02K

SMA 204.28

SMA 503.96

SMA 2003.58

Price vs 50+5.76%

Price vs 200+16.74%

MA stackbullish

50/200 cross—

Supertrendup · 3.77

RSI (14)50

MACD hist-0.06

MACD crossbear · 5d

Stoch %K / %D22 / 24

ADX (14)20

+DI / −DI27 / 21

RSI divergence—

MACD divergence—

ATR %+7.31%

ADR %7.38%

52w high4.86

52w low1.75

From 52w high-13.89%

Above 52w low+139.14%

New 52w highNo

SqueezeOff

Bollinger width29.22%

%B0.43

Donchian pos32.71%

Donchian high5.08

Donchian low3.75

AVWAP (52w high)4.41

vs AVWAP high-5.08%

AVWAP (52w low)3.58

vs AVWAP low+16.80%

OBV trendUp

Chaikin MF (20)-0.01

Today vs 20d1.98×

Avg vol (14d)177.4K

Avg vol (20d)175.56K

Avg $ vol (20d)762.02K

Market cap175.24M

RS 3m (vs SPY)-7.69%

RS 6m (vs SPY)+10.32%

RS line new highNo

Trend template7/8

Technical rank78.8

1 week-0.59%

1 month+2.32%

3 months+7.58%

6 months+15.93%

1 year+84.36%

YTD+19.57%

P/E-15.63

P/B13.66

P/S3.32

P/FCF-19.23

EPS-0.5400

Div yield—

ROE-87.37%

ROA-17.79%

Debt/Eq3.43

Current5.80

EV/EBITDA-32.48

Gross margin62.53%

Net margin-21.22%

Rev growth9.86%

EPS growth52.22%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value188.08M

Revenue12.49M

Net income-2.11M

Gross profit7.92M

Free cash flow-9.12M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out41.87M

Employees205

ListedWed, Apr 6, 1994

Free float32.26M

Float %77.1%

Short interest211.95K

Days to cover1.8d

Short volume31.0%

Squeeze score25 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction72 / 100

Pattern quality—

Tech rank78.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.04

Support3.25

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in APYX

All disclosures →

No recent disclosed trades by Congress in APYX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in APYX · 1 buy · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Roman Shawn David Chief Operating Officer · Common Stock · 2026-06-15	Exercise	15K	$48K	2026-06-15	2026-06-17
Roman Shawn David Chief Operating Officer · Common Stock · 2026-06-15	Tax	10.53K	$48K	2026-06-15	2026-06-17
Roman Shawn David Chief Operating Officer · Stock option (right to buy) · 2026-06-15	Exercise	15K	—	2026-06-15	2026-06-17

SEC filings

EDGAR filings in APYX · 1 recent

EDGAR →

8-K8-KWed, Jun 17, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.